CHU Amiens
CHU Amiens
Amiens, France49 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Perioperative Yoga Therapy and Endometriosis Surgery | Chronic Pain, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, endometriosis, female reproductive system disorder | Not yet recruiting | Not applicable | 2026-10-02 | NCT07765680 | |
| Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 3 | 2026-09-30 | NCT06918002 | |
| ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Not applicable | 2026-09-25 | NCT07545512 | |
| Fever Control Using External Cooling in Mechanically Ventilated Patients With Septic Shock | Body Temperature Changes, Fever, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Signs and Symptoms, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Recruiting | Not applicable | 2026-09-21 | NCT04494074 | |
| Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO | Hemic and Lymphatic Diseases, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Cardiogenic, anemia, cardiovascular disorder, heart disorder, hematologic disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Phase 1 | 2026-09-17 | NCT05699005 | |
| Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Recruiting | Phase 3 | 2026-09-16 | NCT07486024 | |
| Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Active, not recruiting | Phase 2 | 2026-09-11 | NCT06557889 | |
| A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS | Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Active, not recruiting | Phase 3 | 2026-09-11 | NCT03223961 | |
| Multimodal Biocollection Linked to the French Register of Intracranial Aneurysms | Aneurysm, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, brain aneurysm, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, nervous system disorder, vascular disorder | Recruiting | Not applicable | 2026-09-02 | NCT06689410 | |
| Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype | Disease Attributes, Healthcare-Associated Pneumonia, Hospital Acquired Pneumonia, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, iatrogenic disease, lung disorder, nosocomial infection, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 3 | 2026-08-19 | NCT06269900 | |
| Flap Sparing in Postoperative Radiotherapy of Oral Cavity Cancers | Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Site, Stomatognathic Diseases, mouth disorder, neoplasm, oral cavity carcinoma | Recruiting | Phase 3 | 2026-07-22 | NCT06798922 | |
| Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute biphenotypic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, mixed phenotype acute leukemia, neoplasm | Recruiting | Phase 3 | 2026-07-10 | NCT05327894 | |
| Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Phase 2 | 2026-06-22 | NCT04727307 | |
| Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome | Death, Death, Sudden, Infant Death, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sudden Infant Death | Recruiting | Not stated | 2026-06-18 | NCT06244433 | |
| Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid | Severe Forms of Mucous Membrane Pemphigoid | Active, not recruiting | Phase 3 | 2026-06-10 | NCT03295383 | |
| Role of Protective Stoma After Primary Anastomosis for Generalized Peritonitis Due to Perforated Diverticulitis | Digestive System Diseases, Infections, Intraabdominal Infections, Peritoneal Diseases, peritonitis | Recruiting | Not applicable | 2026-06-08 | NCT04604730 | |
| Is Non Surgical CaRE Using Treat to Target Multimodal meDIcal Strategies aBLE to Delay or Avoid Total Knee Replacement? | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Recruiting | Not applicable | 2026-05-22 | NCT06643845 | |
| Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 2 | 2026-05-20 | NCT07205731 | |
| RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures | Bone Diseases, Metabolic, Femoral Fractures, Hip Injuries, Leg Injuries, Nutritional and Metabolic Diseases, bone disorder, bone fracture, hip fracture, injury, metabolic disease, musculoskeletal system disorder, osteoporosis | Recruiting | Not applicable | 2026-05-13 | NCT04796350 | |
| Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets | Embolism, Embolism and Thrombosis, Thromboembolism, Venous Thrombosis, cardiovascular disorder, lung disorder, pulmonary embolism, respiratory system disorder, thrombotic disease, vascular disorder, venous thromboembolism | Recruiting | Phase 3 | 2026-05-08 | NCT05627375 | |
| Single-stage Surgery With Antibiotic-loaded Hydrogel Coated Implants Versus Two Stage Surgery for Secondary Prevention of Complex Chronic Periprosthetic Hip Joint Infection | Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Persistent Infection, split hand-foot malformation 3 | Active, not recruiting | Not applicable | 2026-05-06 | NCT04251377 | |
| the REMONO-CD and the REMONO-UC Studies | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Enrolling by invitation | Not stated | 2026-05-04 | NCT07564609 | |
| Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa | Bacterial Infections and Mycoses, Infections, Pseudomonas infection, bacterial infectious disease, gram-negative bacterial infections | Recruiting | Not stated | 2026-04-30 | NCT06738771 | |
| Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years | Bone Marrow Failure Disorders, Hemic and Lymphatic Diseases, anemia, aplastic anemia, bone marrow disorder, hematologic disorder | Recruiting | Phase 2 | 2026-04-28 | NCT06646497 | |
| Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Phase 2 | 2026-04-27 | NCT06456593 |